Full-Time

Integration & Automation Engineer

Posted on 4/18/2024

Alamar Biosciences

Alamar Biosciences

51-200 employees

Develops proteomic platforms for disease detection

Biotechnology

Compensation Overview

$120,000 - $140,000Annually

+ Bonus + Equity + Benefits

Mid, Senior

Fremont, CA, USA

Required Skills
Python
Requirements
  • Bachelor's in engineering, computer science, biotechnology, physics or a related field, and 5+ years of hands on related experience; or equivalent combination of both.
  • Proficiency in programming languages such as Python or C#.
  • Demonstrated ability to learn and successfully work across multiple disciplines such as engineering, software and assay development teams.
  • Team-oriented and detailed individual with the proven ability to think innovatively toward solving problems effectively and efficiently.
  • Highly self-motivated, eager to take on a wide variety of tasks and grow with evolving technology.
Responsibilities
  • Collaborate within a cross-functional team to design, develop, optimize, and deploy proprietary assay workflows on various instrument platforms.
  • Assist with design, implementation, and optimization of next generation instruments.
  • Troubleshoot complex systems issues related to software, hardware, consumables, and assay integration.
  • Independently design and perform experiments, evaluate or troubleshoot prototypes and instrument performance issues.
  • Help support, maintain and improve existing laboratory automation systems.
  • Ad-hoc instrument troubleshooting, error recovery or repairs.

Alamar Biosciences, Inc. has developed the NULISA™ technology, a next-gen proteomic platform with attomolar sensitivity and high multiplexing capabilities, enabling the detection and quantification of low-abundance proteins and the simultaneous measurement of changes in hundreds to thousands of proteins from a single sample. This breakthrough technology aims to revolutionize the understanding of the human proteome and accelerate biomarker development for early disease detection and prevention.

Company Stage

Series C

Total Funding

$224.3M

Headquarters

Fremont, California

Founded

2018

Growth & Insights
Headcount

6 month growth

9%

1 year growth

25%

2 year growth

73%